LEAP THERAPEUTICS, INC. Annual Weighted Average Number of Shares Outstanding, Basic from 2017 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Leap Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2017 to 2023.
  • Leap Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 39.1M shares, a 166% increase year-over-year.
  • Leap Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 20.4M shares, a 80.5% increase from 2022.
  • Leap Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 11.3M shares, a 86.8% decline from 2021.
  • Leap Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 85.8M shares, a 44.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 20.4M +9.12M +80.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 11.3M -74.5M -86.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 85.8M +26.5M +44.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 59.3M +36.7M +163% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 22.6M +8.44M +59.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 14.1M +4.98M +54.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 9.16M Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.